$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
What kind of medicine is enzalutamide (enzalutamide) mainly used to treat what diseases?
2026-02-01 22:25:32
Check Details
Do I need to continue taking Sorafenib once I start taking it?
2026-02-01 22:25:32
Check Details
Pharmacological characteristics and clinical significance of fostatinib (fotantinib) sodium salt hydrate
2026-02-01 22:25:32
Check Details
Solubility of pirtobrutinib and its impact on absorption
2026-02-01 22:25:32
Check Details
Interpretation of the difference between Lenvatinib (Lenvatinib) and whether it is a targeted drug or an immune drug
2026-02-01 22:25:32
Check Details
Analysis on whether fezolinetant tablets can be purchased in the country and its legality
2026-02-01 22:25:32
Check Details
Detailed explanation of how long it takes for belumosudil to be effective in treating lung transplant rejection
2026-02-01 22:25:32
Check Details
Analysis on whether brivaracetam can be reimbursed by medical insurance and policy interpretation
2026-02-01 22:25:32
Check Details
There are real feedback and experiences from patients using imported obeticholic acid (Obeticholic)
2026-02-01 22:25:32
Check Details
Neratinib (neratinib) usage and dosage standards and patient medication instructions
2026-02-01 22:25:32
Check Details
Will Adalimumab become ineffective after being used for a period of time?
2026-02-01 22:25:32
Check Details
Analysis of expected survival time after treatment with Tislelizumab
2026-02-01 22:25:32
Check Details
1
2
...
1756
1757
1758
1759
1760
1761
1762
...
10226
10227
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
SCEMBLIX (Asciminib) Side Effect Management & Special Population Guide
2
Sabril (Vigabatrin) Explained: Indications, Vision Loss Risk & Key Warnings
3
FDA Approves Tauklarify for Tau PET Imaging in Alzheimer's Disease Assessment
4
First CELMoD Drug Zenbexus Wins FDA Accelerated Approval for Multiple Myeloma
5
Elamipretide Side Effects and Medication Safety Guide: Injection Site Reactions and Storage Essentials
6
Dutasteride Soft Capsules: Comprehensive Side Effect Profile and Management Strategies
7
Oral Semaglutide Tablets: A Complete Guide to the GLP-1 Receptor Agonist for Type 2 Diabetes and Cardiovascular Protection
8
Sotorasib (Lumakras): A Comprehensive Guide to the First KRAS G12C-Targeted Inhibitor
9
Comprehensive Interpretation of Osimertinib: Efficacy, Side Effects and Medication Standards
10
Sotorasib: Can the First KRAS G12C-Targeted Therapy Cure Cancer?
11
Trametinib (Mekinist): Refrigerated Storage, Fasting Administration, and BRAF Mutation Indications Explained
12
Asciminib (SCEMBLIX): STAMP Inhibitor Dosing Guide and Nomenclature Clarification for CML